SHENYANG, China, Jan. 30 3SBio Inc.(Nasdaq: SSRX), a leading China-based biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, announces today that David Chen, VP of Business Development, willpresent at the Merrill Lynch Global Pharmaceutical, Biotechnology and MedicalDevice Conference at The Grand Hyatt hotel in New York on Tuesday, February 5,2008 at 11:00 A.M. (Eastern).
The presentation will be audio webcast live and can be accessed on theEvents section of the investors page of the 3SBio website athttp://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65 . A replay of thepresentation and accompanying slides will be available on the 3SBio websiteuntil February 19, 2008.
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, primarily in China. For more information, please visit 3SBio on theweb at http://www.3sbio.com .For more information, please contact: Investor Contact: Kevin Teo, CFO 3SBio Inc. Tel: +86-24-2581-1820 Investor Relations(HK): Ruby Yim Taylor Rafferty Tel: +852-3196-3712 Investor Relations(US): Mahmoud Siddig Taylor Rafferty Tel: +1-212-889-4350 Media Contact: John Dooley Taylor Rafferty Tel: +1-212-889-4350
SOURCE 3SBio Inc.